Prevention of pruritus with ethyl-chloride in skin prick test: a double-blind placebo-controlled prospective study

被引:1
|
作者
Gal-Oz, Amir [1 ,2 ,3 ]
Kivity, Shmuel [3 ]
Shacham, Yacov [3 ]
Fiszer, Elisheva [3 ]
Rogowsky, Ori [4 ]
Chernin, Gil [1 ,2 ]
机构
[1] Tel Aviv Med Ctr & Sch Med, Tel Aviv Sourasky Med Ctr, Sackler Sch Med, Dept Nephrol, IL-64239 Tel Aviv, Israel
[2] Tel Aviv Med Ctr & Sch Med, Tel Aviv Sourasky Med Ctr, Sackler Sch Med, Med, IL-64239 Tel Aviv, Israel
[3] Tel Aviv Med Ctr & Sch Med, Tel Aviv Sourasky Med Ctr, Sackler Sch Med, Dept Allergy, IL-64239 Tel Aviv, Israel
[4] Tel Aviv Med Ctr & Sch Med, Tel Aviv Sourasky Med Ctr, Sackler Sch Med, Internal Med Dept G Tel Aviv, IL-64239 Tel Aviv, Israel
来源
关键词
Ethyl-chloride spray; Histamine skin-prick test; PAIN REDUCTION; HISTAMINE; FLARE; ITCH; NEUROPHYSIOLOGY; RECEPTORS; RESPONSES; ALLERGY; WHEAL;
D O I
10.1186/s13223-015-0091-z
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Ethyl-chloride (EC) spray was recently shown to be an effective antipruritic agent, when given 15 min after histamine skin-prick test (SPT), without changing the wheal and flare reaction. We aimed to investigate the antipruritic effect of EC on SPT, when given prior to SPT. Methods: A double-blind placebo-controlled prospective study. Overall, 44 volunteers underwent histamine SPT on both arms to trigger local pruritus. Prior to test, they were randomly treated with EC spray on one arm and saline spray (placebo) on the other. Subjects as well as researchers were blinded to the type of applied sprays. The wheal and flare reaction was measured after the SPT and subjects reported the intensity of pruritus following EC/placebo using a validated pruritus questionnaire (indexes 1-3) and a visual analog scale (VAS). Results: Significant improvement in pruritus was reported following treatment with EC compared with placebo for all four studied parameters. Index 1 in EC 3.7 +/- 2.3 versus 5 +/- 3.5 (p = 0.007) in placebo, index 2 in EC 2.6 +/- 2.1 versus 3.8 +/- 2.8 (p = 0.002) in placebo, index 3 of EC 6.3 +/- 3.8 versus 8.8 +/- 5.8 (p = 0.03) and VAS in EC 3.7 +/- 1.9 versus 4.4 +/- 2.3 (p = 0.003). There were no significant differences between EC and placebo in terms of the wheal and flare indurations area. Conclusions: Ethyl-chloride has an effective antipruritic agent, when given before histamine SPT. Its use did not change the wheal and flare reaction, making it ideal for prevention of pruritus, secondary to allergy skin test, without masking the results.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Prevention of pruritus with ethyl-chloride in skin prick test: a double-blind placebo-controlled prospective study
    Amir Gal-Oz
    Shmuel Kivity
    Yacov Shacham
    Elisheva Fiszer
    Ori Rogowsky
    Gil Chernin
    Allergy, Asthma & Clinical Immunology, 11
  • [2] Prevention of pruritus with ethyl-chloride in the skin prick test: a double-blind placebo-controlled prospective study
    Gal-Oz, A.
    Kivity, S.
    Shacham, Y.
    Fiszer, E.
    Rogovsky, O.
    Chernin, G.
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2015, 17 (08): : 528 - 528
  • [3] Ethyl Chloride as an Antipruritic Agent: A Double-Blind Placebo-Controlled Prospective Study
    Gal-Oz, Amir
    Rogowski, Ori
    Swartzon, Michael
    Kivity, Shmuel
    DERMATOLOGY, 2010, 221 (04) : 373 - 377
  • [4] Randomized, double-blind, placebo-controlled study on the immunogenicity of the leishmanin skin test
    De Luca, P. M.
    Mayrink, W.
    Santiago, M. A.
    Nogueira, R.
    Conceicao-Silva, F.
    Melo, G.
    Mendonca, S. C. F.
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2003, 97 (06) : 709 - 712
  • [5] Topiramate in migraine prevention: A double-blind, placebo-controlled study
    Storey, JR
    Calder, CS
    Hart, DE
    Potter, DL
    HEADACHE, 2001, 41 (10): : 968 - 975
  • [6] Oral naltrexone treatment for cholestatic pruritus: A double-blind, placebo-controlled study
    Wolfhagen, FHJ
    Sternieri, E
    Hop, WCJ
    Vitale, G
    Bertolotti, M
    vanBuuren, HR
    GASTROENTEROLOGY, 1997, 113 (04) : 1264 - 1269
  • [7] OXATOMIDE IN THE TREATMENT OF PRURITUS SENILIS - A DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL
    DUPONT, C
    DEMAUBEUGE, J
    KOTLAR, W
    LAYS, Y
    MASSON, M
    DERMATOLOGICA, 1984, 169 (06): : 348 - 353
  • [8] CANDICIDIN TREATMENT OF PROSTATISM - A PROSPECTIVE DOUBLE-BLIND PLACEBO-CONTROLLED STUDY
    JENSEN, KME
    MADSEN, PO
    UROLOGICAL RESEARCH, 1983, 11 (01): : 7 - 10
  • [9] Efficacy of oral naltrexone on pruritus in atopic eczema: a double-blind, placebo-controlled study
    Malekzad, F.
    Arbabi, M.
    Mohtasham, N.
    Toosi, P.
    Jaberian, M.
    Mohajer, M.
    Mohammadi, M. R.
    Roodsari, M. R.
    Nasiri, S.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2009, 23 (08) : 948 - 950
  • [10] SENSITIVITY OF THE DIPYRIDAMOLE TEST - A PLACEBO-CONTROLLED DOUBLE-BLIND CROSSOVER STUDY
    EHLING, J
    WESSEL, HJ
    SCHUREN, KP
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1984, 109 (39) : 1481 - 1485